Avidity Biosciences (RNA) Revenue & Revenue Breakdown
Avidity Biosciences Revenue Highlights
Latest Revenue (Y)
$18.75M
Latest Revenue (Q)
$12.47M
Main Segment (Y)
Reportable Segment
Avidity Biosciences Revenue by Period
Avidity Biosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $18.75M | 72.11% |
| 2024-12-31 | $10.90M | 13.99% |
| 2023-12-31 | $9.56M | 3.64% |
| 2022-12-31 | $9.22M | -1.09% |
| 2021-12-31 | $9.33M | 37.41% |
| 2020-12-31 | $6.79M | 192.67% |
| 2019-12-31 | $2.32M | 511.87% |
| 2018-12-31 | $379.00K | - |
Avidity Biosciences generated $18.75M in revenue during NA 2025, up 72.11% compared to the previous quarter, and up 276.34% compared to the same period a year ago.
Avidity Biosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $12.47M | 224.28% |
| 2025-06-30 | $3.85M | 144.56% |
| 2025-03-31 | $1.57M | -47.09% |
| 2024-12-31 | $2.97M | 27.27% |
| 2024-09-30 | $2.34M | 14.23% |
| 2024-06-30 | $2.04M | -42.28% |
| 2024-03-31 | $3.54M | 61.56% |
| 2023-12-31 | $2.19M | -22.18% |
| 2023-09-30 | $2.82M | 21.68% |
| 2023-06-30 | $2.32M | 3.72% |
| 2023-03-31 | $2.23M | -19.36% |
| 2022-12-31 | $2.77M | 11.56% |
| 2022-09-30 | $2.48M | 13.96% |
| 2022-06-30 | $2.18M | 21.34% |
| 2022-03-31 | $1.79M | -3.08% |
| 2021-12-31 | $1.85M | -14.38% |
| 2021-09-30 | $2.16M | -17.03% |
| 2021-06-30 | $2.61M | -3.59% |
| 2021-03-31 | $2.70M | 26.24% |
| 2020-12-31 | $2.14M | 22.68% |
| 2020-09-30 | $1.75M | 13.30% |
| 2020-06-30 | $1.54M | 13.48% |
| 2020-03-31 | $1.36M | -6.02% |
| 2019-12-31 | $1.45M | 122.31% |
| 2019-09-30 | $650.00K | 190.18% |
| 2019-06-30 | $224.00K | 100.00% |
| 2019-03-31 | - | - |
Avidity Biosciences generated $12.47M in revenue during Q3 2025, up 224.28% compared to the previous quarter, and up 610.02% compared to the same period a year ago.
Avidity Biosciences Revenue Breakdown
Avidity Biosciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 |
|---|---|---|
| Reportable Segment | $18.75M | $10.90M |
Latest
Avidity Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 25: Reportable Segment (100.00%).
Quarterly Revenue by Product
| Product/Service | Dec 25 | Sep 25 | Jun 25 | Mar 25 |
|---|---|---|---|---|
| Reportable Segment | $860.00K | $12.47M | $3.85M | $1.57M |
Latest
Avidity Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Reportable Segment (100.00%).
Avidity Biosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals | $4.27B | $1.05B |
| MRNA | Moderna | $1.94B | $1.02B |
| TECH | Bio-Techne | $1.16B | $295.88M |
| MDGL | Madrigal Pharmaceuticals | $958.40M | $287.27M |
| CAI | Caris Life Sciences | $294.01M | $216.83M |
| RYTM | Rhythm Pharmaceuticals | $189.76M | $51.30M |
| CYTK | Cytokinetics | $88.04M | $66.77M |
| MRUS | Merus | $36.13M | $12.15M |
| RNA | Avidity Biosciences | $18.75M | $12.47M |
| NUVL | Nuvalent | - | - |
| ABVX | Abivax | - | - |